G protein-coupled receptor and RhoA-stimulated transcriptional responses: Links to inflammation, differentiation, and cell proliferation

Molecular Pharmacology

Volumn 88, Issue 1, 2015, Pages 171-180

  Yu, Olivia M ^a   Brown, Joan Heller ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYCLOOXYGENASE 2; CYSTEINE RICH PROTEIN 61; G PROTEIN COUPLED RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYOCARDIN; PHOSPHOLIPASE C; PHOSPHOLIPASE C EPSILON; RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; YES ASSOCIATED PROTEIN;

CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYME ACTIVATION; FIBROSIS; GENE CONTROL; HUMAN; INFLAMMATION; NEOPLASM; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; GENE EXPRESSION REGULATION; METABOLISM; MUCOLIPIDOSIS; PATHOLOGY;

ANIMALS; CARDIOVASCULAR DISEASES; CELL PROLIFERATION; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; MUCOLIPIDOSES; NEOPLASMS; RECEPTORS, G-PROTEIN-COUPLED; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION;

EID: 84940173841     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.115.097857     Document Type: Review

References (145)

1. Angel P, Imagawa M, Chiu R, Stein B, Imbra RJ, Rahmsdorf HJ, Jonat C, Herrlich P, and Karin M (1987) Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49:729-739.
2. Anwar KN, Fazal F, Malik AB, and Rahman A (2004) RhoA/Rho-associated kinase pathway selectively regulates thrombin-induced intercellular adhesion molecule-1 expression in endothelial cells via activation of I kappa B kinase beta and phosphorylation of RelA/p65. J Immunol 173:6965-6972.
3. Aragay AM, Collins LR, Post GR, Watson AJ, Feramisco JR, Brown JH, and Simon MI (1995) G12 requirement for thrombin-stimulated gene expression and DNA synthesis in 1321N1 astrocytoma cells. J Biol Chem 270:20073-20077.
4. Aragona M, Panciera T, Manfrin A, Giulitti S, Michielin F, Elvassore N, Dupont S, and Piccolo S (2013) A mechanical checkpoint controls multicellular growth through YAP/TAZ regulation by actin-processing factors. Cell 154:1047-1059.
5. Arora P, Cuevas BD, Russo A, Johnson GL, and Trejo J (2008) Persistent transactivation of EGFR and ErbB2/HER2 by protease-activated receptor-1 promotes breast carcinoma cell invasion. Oncogene 27:4434-4445.
6. Azzolin L, Panciera T, Soligo S, Enzo E, Bicciato S, Dupont S, Bresolin S, Frasson C, Basso G, and Guzzardo V et al. (2014) YAP/TAZ incorporation in the β-catenin destruction complex orchestrates the Wnt response. Cell 158:157-170.
7. Baarlink C, Wang H, and Grosse R (2013) Nuclear actin network assembly by formins regulates the SRF coactivator MAL. Science 340:864-867.
8. Benitah SA, Valerón PF, and Lacal JC (2003) ROCK and nuclear factor-kappaB-dependent activation of cyclooxygenase-2 by Rho GTPases: effects on tumor growth and therapeutic consequences. Mol Biol Cell 14:3041-3054.
9. Camargo FD, Gokhale S, Johnnidis JB, Fu D, Bell GW, Jaenisch R, and Brummelkamp TR (2007) YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol 17:2054-2060.
10. Cammarano MS and Minden A (2001) Dbl and the Rho GTPases activate NF kappa B by I kappa B kinase (IKK)-dependent and IKK-independent pathways. J Biol Chem 276:25876-25882.
11. Cen B, Selvaraj A, Burgess RC, Hitzler JK, Ma Z, Morris SW, and Prywes R (2003) Megakaryoblastic leukemia 1, a potent transcriptional coactivator for serum response factor (SRF), is required for serum induction of SRF target genes. Mol Cell Biol 23:6597-6608.
12. Cen B, Selvaraj A, and Prywes R (2004) Myocardin/MKL family of SRF coactivators: key regulators of immediate early and muscle specific gene expression. J Cell Biochem 93:74-82.
13. Chikumi H, Vázquez-Prado J, Servitja JM, Miyazaki H, and Gutkind JS (2002) Potent activation of RhoA by Galpha q and Gq-coupled receptors. J Biol Chem 277:27130-27134.
14. Chiu TT, Leung WY, Moyer MP, Strieter RM, and Rozengurt E (2007) Protein kinase D2 mediates lysophosphatidic acid-induced interleukin 8 production in non-transformed human colonic epithelial cells through NF-kappaB. Am J Physiol Cell Physiol 292:C767-C777.
15. Citro S, Malik S, Oestreich EA, Radeff-Huang J, Kelley GG, Smrcka AV, and Brown JH (2007) Phospholipase Cepsilon is a nexus for Rho and Rap-mediated G protein-coupled receptor-induced astrocyte proliferation. Proc Natl Acad Sci USA 104:15543-15548.
16. Collins LR, Minden A, Karin M, and Brown JH (1996) Galpha12 stimulates c-Jun NH2-terminal kinase through the small G proteins Ras and Rac. J Biol Chem 271:17349-17353.
17. Coso OA, Chiariello M, Kalinec G, Kyriakis JM, Woodgett J, and Gutkind JS (1995) Transforming G protein-coupled receptors potently activate JNK (SAPK). Evidence for a divergence from the tyrosine kinase signaling pathway. J Biol Chem 270:5620-5624.
18. Coso OA, Montaner S, Fromm C, Lacal JC, Prywes R, Teramoto H, and Gutkind JS (1997) Signaling from G protein-coupled receptors to the c-jun promoter involves the MEF2 transcription factor. Evidence for a novel c-jun amino-terminal kinase-independent pathway. J Biol Chem 272:20691-20697.
19. Cui R, Tieu B, Recinos A, Tilton RG, and Brasier AR (2006) RhoA mediates angiotensin II-induced phospho-Ser536 nuclear factor kappaB/RelA subunit exchange on the interleukin-6 promoter in VSMCs. Circ Res 99:723-730.
20. Daub H, Weiss FU, Wallasch C, and Ullrich A (1996) Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 379:557-560.
21. Del Re DP, Miyamoto S, and Brown JH (2007) RhoA/Rho kinase up-regulate Bax to activate a mitochondrial death pathway and induce cardiomyocyte apoptosis. J Biol Chem 282:8069-8078.
22. Del Re DP, Yang Y, Nakano N, Cho J, Zhai P, Yamamoto T, Zhang N, Yabuta N, Nojima H, and Pan D et al. (2013) Yes-associated protein isoform 1 (Yap1) promotes cardiomyocyte survival and growth to protect against myocardial ischemic injury. J Biol Chem 288:3977-3988.
23. Djellas Y, Manganello JM, Antonakis K, and Le Breton GC (1999) Identification of Galpha13 as one of the G-proteins that couple to human platelet thromboxane A2 receptors. J Biol Chem 274:14325-14330.
24. Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi M, Zanconato F, Le Digabel J, Forcato M, and Bicciato S et al. (2011) Role of YAP/TAZ in mechanotransduction. Nature 474:179-183.
25. Dusaban SS and Brown JH (2015) PLCε mediated sustained signaling pathways. Adv Biol Regul 57:17-23.
26. Dusaban SS, Purcell NH, Rockenstein E, Masliah E, Cho MK, Smrcka AV, and Brown JH (2013) Phospholipase C epsilon links G protein-coupled receptor activation to inflammatory astrocytic responses. Proc Natl Acad Sci USA 110:3609-3614.
27. Esnault C, Stewart A, Gualdrini F, East P, Horswell S, Matthews N, and Treisman R (2014) Rho-actin signaling to the MRTF coactivators dominates the immediate transcriptional response to serum in fibroblasts. Genes Dev 28:943-958.
28. Evans T, Hepler JR, Masters SB, Brown JH, and Harden TK (1985) Guanine nucleotide regulation of agonist binding to muscarinic cholinergic receptors. Relation to efficacy of agonists for stimulation of phosphoinositide breakdown and Ca2+ mobilization. Biochem J 232:751-757.
29. Evelyn CR, Wade SM, Wang Q, Wu M, Iñiguez-Lluhí JA, Merajver SD, and Neubig RR (2007) CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling. Mol Cancer Ther 6:2249-2260.
30. Feng X, Degese MS, Iglesias-Bartolome R, Vaque JP, Molinolo AA, Rodrigues M, Zaidi MR, Ksander BR, Merlino G, and Sodhi A et al. (2014) Hippo-independent activation of YAP by the GNAQ uveal melanoma oncogene through a trio-regulated rho GTPase signaling circuitry. Cancer Cell 25:831-845.
31. Fu Y and Rubin CS (2011) Protein kinase D: coupling extracellular stimuli to the regulation of cell physiology. EMBO Rep 12:785-796.
32. Guettler S, Vartiainen MK, Miralles F, Larijani B, and Treisman R (2008) RPEL motifs link the serum response factor cofactor MAL but not myocardin to Rho signaling via actin binding. Mol Cell Biol 28:732-742.
33. Gutkind JS, Novotny EA, Brann MR, and Robbins KC (1991) Muscarinic acetylcholine receptor subtypes as agonist-dependent oncogenes. Proc Natl Acad Sci USA 88:4703-4707.
34. Haak AJ, Tsou PS, Amin MA, Ruth JH, Campbell P, Fox DA, Khanna D, Larsen SD, and Neubig RR (2014) Targeting the myofibroblast genetic switch: inhibitors of myocardin-related transcription factor/serum response factor-regulated gene transcription prevent fibrosis in a murine model of skin injury. J Pharmacol Exp Ther 349:480-486.
35. Hall A (1998) Rho GTPases and the actin cytoskeleton. Science 279:509-514.
36. Han JS, Macarak E, Rosenbloom J, Chung KC, and Chaqour B (2003) Regulation of Cyr61/CCN1 gene expression through RhoA GTPase and p38MAPK signaling pathways. Eur J Biochem 270:3408-3421.
37. Hanna M, Liu H, Amir J, Sun Y, Morris SW, Siddiqui MA, Lau LF, and Chaqour B (2009) Mechanical regulation of the proangiogenic factor CCN1/CYR61 gene requires the combined activities of MRTF-A and CREB-binding protein histone acetyltransferase. J Biol Chem 284:23125-23136.
38. Hao Y, Chun A, Cheung K, Rashidi B, and Yang X (2008) Tumor suppressor LATS1 is a negative regulator of oncogene YAP. J Biol Chem 283:5496-5509.
39. Hart MJ, Jiang X, Kozasa T, Roscoe W, Singer WD, Gilman AG, Sternweis PC, and Bollag G (1998) Direct stimulation of the guanine nucleotide exchange activity of p115 RhoGEF by Galpha13. Science 280:2112-2114.
40. Hill CS, Wynne J, and Treisman R (1995) The Rho family GTPases RhoA, Rac1, and CDC42Hs regulate transcriptional activation by SRF. Cell 81:1159-1170.
41. Hinkel R, Trenkwalder T, Petersen B, Husada W, Gesenhues F, Lee S, Hannappel E, Bock-Marquette I, Theisen D, and Leitner L et al. (2014) MRTF-A controls vessel growth and maturation by increasing the expression of CCN1 and CCN2. Nat Commun 5:3970.
42. Hinson JS, Medlin MD, Lockman K, Taylor JM, and Mack CP (2007) Smooth muscle cell-specific transcription is regulated by nuclear localization of the myocardin-related transcription factors. Am J Physiol Heart Circ Physiol 292:H1170-H1180.
43. Hollenberg MD, Mihara K, Polley D, Suen JY, Han A, Fairlie DP, and Ramachandran R (2014) Biased signalling and proteinase-activated receptors (PARs): targeting inflammatory disease. Br J Pharmacol 171:1180-1194.
44. Hsu YL, Hung JY, Chou SH, Huang MS, Tsai MJ, Lin YS, Chiang SY, Ho YW, Wu CY, and Kuo PL (2014) Angiomotin decreases lung cancer progression by sequestering oncogenic YAP/TAZ and decreasing Cyr61 expression. Oncogene DOI: 10.1038/onc.2014.333 [published ahead of print].
45. Huang J, Wu S, Barrera J, Matthews K, and Pan D (2005) The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP. Cell 122:421-434.
46. Huang S, Chen LY, Zuraw BL, Ye RD, and Pan ZK (2001) Chemoattractant-stimulated NF-kappaB activation is dependent on the low molecular weight GTPase RhoA. J Biol Chem 276:40977-40981.
47. Hwang YS, Hodge JC, Sivapurapu N, and Lindholm PF (2006) Lysophosphatidic acid stimulates PC-3 prostate cancer cell Matrigel invasion through activation of RhoA and NF-kappaB activity. Mol Carcinog 45:518-529.
48. Imajo M, Miyatake K, Iimura A, Miyamoto A, and Nishida E (2012) A molecular mechanism that links Hippo signalling to the inhibition of Wnt/β-catenin signalling. EMBO J 31:1109-1122.
49. Ishii I, Friedman B, Ye X, Kawamura S, McGiffert C, Contos JJ, Kingsbury MA, Zhang G, Brown JH, and Chun J (2001) Selective loss of sphingosine 1-phosphate signaling with no obvious phenotypic abnormality in mice lacking its G protein-coupled receptor, LP(B3)/EDG-3. J Biol Chem 276:33697-33704.
50. Jun JI and Lau LF (2011) Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets. Nat Rev Drug Discov 10:945-963.
51. Kaibuchi K, Kuroda S, and Amano M (1999) Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells. Annu Rev Biochem 68:459-486.
52. Kang WK, Lee I, and Park C (2005) Characterization of RhoA-mediated chemoresistance in gastric cancer cells. Cancer Res Treat 37:251-256.
53. Karin M (1995) The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 270:16483-16486.
54. Karliner JS (2009) Sphingosine kinase and sphingosine 1-phosphate in cardioprotection. J Cardiovasc Pharmacol 53:189-197.
55. Kawanami D, Matoba K, Kanazawa Y, Ishizawa S, Yokota T, and Utsunomiya K (2011) Thrombin induces MCP-1 expression through Rho-kinase and subsequent p38MAPK/NF-κB signaling pathway activation in vascular endothelial cells. Biochem Biophys Res Commun 411:798-803.
56. Ki SH, Choi MJ, Lee CH, and Kim SG (2007) Galpha12 specifically regulates COX-2 induction by sphingosine 1-phosphate. Role for JNK-dependent ubiquitination and degradation of IkappaBalpha. J Biol Chem 282:1938-1947.
57. Kim KH, Chen CC, Monzon RI, and Lau LF (2013) Matricellular protein CCN1 promotes regression of liver fibrosis through induction of cellular senescence in hepatic myofibroblasts. Mol Cell Biol 33:2078-2090.
58. Kim YM, Lim SC, Han CY, Kay HY, Cho IJ, Ki SH, Lee MY, Kwon HM, Lee CH, and Kim SG (2011) G(alpha)12/13 induction of CYR61 in association with arteriosclerotic intimal hyperplasia: effect of sphingosine-1-phosphate. Arterioscler Thromb Vasc Biol 31:861-869.
59. Kitazawa T, Masuo M, and Somlyo AP (1991) G protein-mediated inhibition of myosin light-chain phosphatase in vascular smooth muscle. Proc Natl Acad Sci USA 88:9307-9310.
60. Klemm S, Zimmermann S, Peschel C, Mak TW, and Ruland J (2007) Bcl10 and Malt1 control lysophosphatidic acid-induced NF-kappaB activation and cytokine production. Proc Natl Acad Sci USA 104:134-138.
61. Krakstad BF, Ardawatia VV, and Aragay AM (2004) A role for Galpha12/Galpha13 in p120ctn regulation. Proc Natl Acad Sci USA 101:10314-10319.
62. Kujubu DA, Fletcher BS, Varnum BC, Lim RW, and Herschman HR (1991) TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 266:12866-12872.
63. Lau LF (2011) CCN1/CYR61: the very model of a modern matricellular protein. Cell Mol Life Sci 68:3149-3163.
64. Lee W, Mitchell P, and Tjian R (1987) Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell 49:741-752.
65. Leonard A, Marando C, Rahman A, and Fazal F (2013) Thrombin selectively engages LIM kinase 1 and slingshot-1L phosphatase to regulate NF-κB activation and endothelial cell inflammation. Am J Physiol Lung Cell Mol Physiol 305:L651-L664.
66. Li J, Gao E, Vite A, Yi R, Gomez L, Goossens S, van Roy F, and Radice GL (2015) Alpha-catenins control cardiomyocyte proliferation by regulating Yap activity. Circ Res 116:70-79.
67. Lockman K, Hinson JS, Medlin MD, Morris D, Taylor JM, and Mack CP (2004) Sphingosine 1-phosphate stimulates smooth muscle cell differentiation and proliferation by activating separate serum response factor co-factors. J Biol Chem 279:42422-42430.
68. Mack CP (2011) Signaling mechanisms that regulate smooth muscle cell differentiation. Arterioscler Thromb Vasc Biol 31:1495-1505.
69. Majumdar M, Seasholtz TM, Goldstein D, de Lanerolle P, and Brown JH (1998) Requirement for Rho-mediated myosin light chain phosphorylation in thrombin-stimulated cell rounding and its dissociation from mitogenesis. J Biol Chem 273:10099-10106.
70. Marinissen MJ, Chiariello M, Tanos T, Bernard O, Narumiya S, and Gutkind JS (2004) The small GTP-binding protein RhoA regulates c-jun by a ROCK-JNK signaling axis. Mol Cell 14:29-41.
71. Masters SB, Harden TK, and Brown JH (1984) Relationships between phosphoinositide and calcium responses to muscarinic agonists in astrocytoma cells. Mol Pharmacol 26:149-155.
72. McAllister-Lucas LM, Ruland J, Siu K, Jin X, Gu S, Kim DS, Kuffa P, Kohrt D, Mak TW, and Nuñez G et al. (2007) CARMA3/Bcl10/MALT1-dependent NF-kappaB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cells. Proc Natl Acad Sci USA 104:139-144.
73. Means CK, Xiao CY, Li Z, Zhang T, Omens JH, Ishii I, Chun J, and Brown JH (2007) Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 292:H2944-H2951.
74. Minami T, Kuwahara K, Nakagawa Y, Takaoka M, Kinoshita H, Nakao K, Kuwabara Y, Yamada Y, Yamada C, and Shibata J et al. (2012) Reciprocal expression of MRTF-A and myocardin is crucial for pathological vascular remodelling in mice. EMBO J 31:4428-4440.
75. Miralles F, Posern G, Zaromytidou AI, and Treisman R (2003) Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell 113:329-342.
76. Mo JS, Park HW, and Guan KL (2014) The Hippo signaling pathway in stem cell biology and cancer. EMBO Rep 15:642-656.
77. Mo JS, Yu FX, Gong R, Brown JH, and Guan KL (2012) Regulation of the Hippo-YAP pathway by protease-activated receptors (PARs). Genes Dev 26:2138-2143.
78. Moers A, Nieswandt B, Massberg S, Wettschureck N, Grüner S, Konrad I, Schulte V, Aktas B, Gratacap MP, and Simon MI et al. (2003) G13 is an essential mediator of platelet activation in hemostasis and thrombosis. Nat Med 9:1418-1422.
79. Montaner S, Perona R, Saniger L, and Lacal JC (1999) Activation of serum response factor by RhoA is mediated by the nuclear factor-kappaB and C/EBP transcription factors. J Biol Chem 274:8506-8515.
80. Mutoh T, Rivera R, and Chun J (2012) Insights into the pharmacological relevance of lysophospholipid receptors. Br J Pharmacol 165:829-844.
81. Narumiya S, Tanji M, and Ishizaki T (2009) Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion. Cancer Metastasis Rev 28:65-76.
82. Nicole O, Goldshmidt A, Hamill CE, Sorensen SD, Sastre A, Lyuboslavsky P, Hepler JR, McKeon RJ, and Traynelis SF (2005) Activation of protease-activated receptor-1 triggers astrogliosis after brain injury. J Neurosci 25:4319-4329.
83. Nobes CD, Hawkins P, Stephens L, and Hall A (1995) Activation of the small GTP-binding proteins rho and rac by growth factor receptors. J Cell Sci 108:225-233.
84. Norman C, Runswick M, Pollock R, and Treisman R (1988) Isolation and properties of cDNA clones encoding SRF, a transcription factor that binds to the c-fos serum response element. Cell 55:989-1003.
85. Olson EN and Nordheim A (2010) Linking actin dynamics and gene transcription to drive cellular motile functions. Nat Rev Mol Cell Biol 11:353-365.
86. Olson MF, Paterson HF, and Marshall CJ (1998) Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1/Cip1. Nature 394:295-299.
87. Overholtzer M, Zhang J, Smolen GA, Muir B, Li W, Sgroi DC, Deng CX, Brugge JS, and Haber DA (2006) Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc Natl Acad Sci USA 103:12405-12410.
88. Pan ZK, Ye RD, Christiansen SC, Jagels MA, Bokoch GM, and Zuraw BL (1998) Role of the Rho GTPase in bradykinin-stimulated nuclear factor-kappaB activation and IL-1beta gene expression in cultured human epithelial cells. J Immunol 160:3038-3045.
89. Pandey S and Wang E (1995) Cells en route to apoptosis are characterized by the upregulation of c-fos, c-myc, c-jun, cdc2, and RB phosphorylation, resembling events of early cell-cycle traverse. J Cell Biochem 58:135-150.
90. Parmacek MS (2007) Myocardin-related transcription factors: critical coactivators regulating cardiovascular development and adaptation. Circ Res 100:633-644.
91. Perona R, Montaner S, Saniger L, Sánchez-Pérez I, Bravo R, and Lacal JC (1997) Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins. Genes Dev 11:463-475.
92. Post GR, Collins LR, Kennedy ED, Moskowitz SA, Aragay AM, Goldstein D, and Brown JH (1996) Coupling of the thrombin receptor to G12 may account for selective effects of thrombin on gene expression and DNA synthesis in 1321N1 astrocytoma cells. Mol Biol Cell 7:1679-1690.
93. Qiu RG, Chen J, McCormick F, and Symons M (1995) A role for Rho in Ras transformation. Proc Natl Acad Sci USA 92:11781-11785.
94. Quan T, Xu Y, Qin Z, Robichaud P, Betcher S, Calderone K, He T, Johnson TM, Voorhees JJ, and Fisher GJ (2014) Elevated YAP and its downstream targets CCN1 and CCN2 in basal cell carcinoma: impact on keratinocyte proliferation and stromal cell activation. Am J Pathol 184:937-943.
95. Ren XD, Kiosses WB, and Schwartz MA (1999) Regulation of the small GTP-binding protein Rho by cell adhesion and the cytoskeleton. EMBO J 18:578-585.
96. Ridley AJ and Hall A (1992) The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70:389-399.
97. Rossol-Allison J, Stemmle LN, Swenson-Fields KI, Kelly P, Fields PE, McCall SJ, Casey PJ, and Fields TA (2009) Rho GTPase activity modulates Wnt3a/beta-catenin signaling. Cell Signal 21:1559-1568.
98. Sahai E, Alberts AS, and Treisman R (1998) RhoA effector mutants reveal distinct effector pathways for cytoskeletal reorganization, SRF activation and transformation. EMBO J 17:1350-1361.
99. Segain JP, Raingeard de la Blétière D, Sauzeau V, Bourreille A, Hilaret G, Cario-Toumaniantz C, Pacaud P, Galmiche JP, and Loirand G (2003) Rho kinase blockade prevents inflammation via nuclear factor kappa B inhibition: evidence in Crohn's disease and experimental colitis. Gastroenterology 124:1180-1187.
100. Seifert JP, Wing MR, Snyder JT, Gershburg S, Sondek J, and Harden TK (2004) RhoA activates purified phospholipase C-epsilon by a guanine nucleotide-dependent mechanism. J Biol Chem 279:47992-47997.
101. Shankaranarayanan A, Boguth CA, Lutz S, Vettel C, Uhlemann F, Aittaleb M, Wieland T, and Tesmer JJ (2010) Galpha q allosterically activates and relieves autoinhibition of p63RhoGEF. Cell Signal 22:1114-1123.
102. Shaw PE, Schröter H, and Nordheim A (1989) The ability of a ternary complex to form over the serum response element correlates with serum inducibility of the human c-fos promoter. Cell 56:563-572.
103. Siehler S, Wang Y, Fan X, Windh RT, and Manning DR (2001) Sphingosine 1-phosphate activates nuclear factor-kappa B through Edg receptors. Activation through Edg-3 and Edg-5, but not Edg-1, in human embryonic kidney 293 cells. J Biol Chem 276:48733-48739.
104. Sivaraj KK, Takefuji M, Schmidt I, Adams RH, Offermanns S, and Wettschureck N (2013) G13 controls angiogenesis through regulation of VEGFR-2 expression. Dev Cell 25:427-434.
105. Slice LW, Bui L, Mak C, and Walsh JH (2000) Differential regulation of COX-2 transcription by Ras- and Rho-family of GTPases. Biochem Biophys Res Commun 276:406-410.
106. Slice LW, Han SK, and Simon MI (2003) Galphaq signaling is required for Rho-dependent transcriptional activation of the cyclooxygenase-2 promoter in fibroblasts. J Cell Physiol 194:127-138.
107. Slice LW, Walsh JH, and Rozengurt E (1999) Galpha(13) stimulates Rho-dependent activation of the cyclooxygenase-2 promoter. J Biol Chem 274:27562-27566.
108. Small EM, Thatcher JE, Sutherland LB, Kinoshita H, Gerard RD, Richardson JA, Dimaio JM, Sadek H, Kuwahara K, and Olson EN (2010) Myocardin-related transcription factor-a controls myofibroblast activation and fibrosis in response to myocardial infarction. Circ Res 107:294-304.
109. Smrcka AV, Brown JH, and Holz GG (2012) Role of phospholipase Cε in physiological phosphoinositide signaling networks. Cell Signal 24:1333-1343.
110. Soh UJ and Trejo J (2011) Activated protein C promotes protease-activated receptor-1 cytoprotective signaling through b-arrestin and dishevelled-2 scaffolds. Proc Natl Acad Sci USA 108:E1372-E1380.
111. Sorensen SD, Nicole O, Peavy RD, Montoya LM, Lee CJ, Murphy TJ, Traynelis SF, and Hepler JR (2003) Common signaling pathways link activation of murine PAR-1, LPA, and S1P receptors to proliferation of astrocytes. Mol Pharmacol 64:1199-1209.
112. Staus DP, Weise-Cross L, Mangum KD, Medlin MD, Mangiante L, Taylor JM, and Mack CP (2014) Nuclear RhoA signaling regulates MRTF-dependent SMC-specific transcription. Am J Physiol Heart Circ Physiol 307:H379-H390.
113. Syeda F, Grosjean J, Houliston RA, Keogh RJ, Carter TD, Paleolog E, and Wheeler-Jones CP (2006) Cyclooxygenase-2 induction and prostacyclin release by protease-activated receptors in endothelial cells require cooperation between mitogen-activated protein kinase and NF-kappaB pathways. JBiolChem281:11792-11804.
114. Tanabe S, Kreutz B, Suzuki N, and Kozasa T (2004) Regulation of RGS-RhoGEFs by Galpha12 and Galpha13 proteins. Methods Enzymol 390:285-294.
115. Thumkeo D, Watanabe S, and Narumiya S (2013) Physiological roles of Rho and Rho effectors in mammals. Eur J Cell Biol 92:303-315.
116. Trejo J, Chambard JC, Karin M, and Brown JH (1992) Biphasic increase in c-jun mRNA is required for induction of AP-1-mediated gene transcription: differential effects of muscarinic and thrombin receptor activation. Mol Cell Biol 12:4742-750.
117. Vaqué JP, Dorsam RT, Feng X, Iglesias-Bartolome R, Forsthoefel DJ, Chen Q, Debant A, Seeger MA, Ksander BR, and Teramoto H et al. (2013) A genome-wide RNAi screen reveals a Trio-regulated Rho GTPase circuitry transducing mitogenic signals initiated by G protein-coupled receptors. Mol Cell 49:94-108.
118. Vartiainen MK, Guettler S, Larijani B, and Treisman R (2007) Nuclear actin regulates dynamic subcellular localization and activity of the SRF cofactor MAL. Science 316:1749-1752.
119. Vassilev A, Kaneko KJ, Shu H, Zhao Y, and DePamphilis ML (2001) TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm. Genes Dev 15:1229-1241.
120. Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D, and Miyamoto S (1995) Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev 9:2723-2735.
121. Violin JD and Lefkowitz RJ (2007) Beta-arrestin-biased ligands at seven-transmembrane receptors. Trends Pharmacol Sci 28:416-422.
122. Walsh CT, Radeff-Huang J, Matteo R, Hsiao A, Subramaniam S, Stupack D, and Brown JH (2008a) Thrombin receptor and RhoA mediate cell proliferation through integrins and cysteine-rich protein 61. FASEB J 22:4011-4021.
123. Walsh CT, Stupack D, and Brown JH (2008b) G protein-coupled receptors go extracellular: RhoA integrates the integrins. Mol Interv 8:165-173.
124. Wang D, You Y, Lin PC, Xue L, Morris SW, Zeng H, Wen R, and Lin X (2007) Bcl10 plays a critical role in NF-kappaB activation induced by G protein-coupled receptors. Proc Natl Acad Sci USA 104:145-150.
125. Wang Y, Falasca M, Schlessinger J, Malstrom S, Tsichlis P, Settleman J, Hu W, Lim B, and Prywes R (1998) Activation of the c-fos serum response element by phosphatidyl inositol 3-kinase and rho pathways in HeLa cells. Cell Growth Differ 9:513-522.
126. Wang Z, Wang DZ, Pipes GC, and Olson EN (2003) Myocardin is a master regulator of smooth muscle gene expression. Proc Natl Acad Sci USA 100:7129-7134.
127. Weinl C, Riehle H, Park D, Stritt C, Beck S, Huber G, Wolburg H, Olson EN, Seeliger MW, and Adams RH et al. (2013) Endothelial SRF/MRTF ablation causes vascular disease phenotypes in murine retinae. J Clin Invest 123:2193-2206.
128. Wing MR, Snyder JT, Sondek J, and Harden TK (2003) Direct activation of phospholipase C-epsilon by Rho. J Biol Chem 278:41253-41258.
129. Wisdom R, Johnson RS, and Moore C (1999) c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms. EMBO J 18:188-197.
130. Xiang SY, Ouyang K, Yung BS, Miyamoto S, Smrcka AV, Chen J, and Heller Brown J (2013) PLCε, PKD1, and SSH1L transduce RhoA signaling to protect mitochondria from oxidative stress in the heart. Sci Signal 6:ra108.
131. Xiang SY, Vanhoutte D, Del Re DP, Purcell NH, Ling H, Banerjee I, Bossuyt J, Lang RA, Zheng Y, and Matkovich SJ et al. (2011) RhoA protects the mouse heart against ischemia/reperfusion injury. J Clin Invest 121:3269-3276.
132. Xin M, Kim Y, Sutherland LB, Murakami M, Qi X, McAnally J, Porrello ER, Mahmoud AI, Tan W, and Shelton JM et al. (2013) Hippo pathway effector Yap promotes cardiac regeneration. Proc Natl Acad Sci USA 110:13839-13844.
133. Yagi R, Chen LF, Shigesada K, Murakami Y, and Ito Y (1999) A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator. EMBO J 18:2551-2562.
134. Young N, Pearl DK, and Van Brocklyn JR (2009) Sphingosine-1-phosphate regulates glioblastoma cell invasiveness through the urokinase plasminogen activator system and CCN1/Cyr61. Mol Cancer Res 7:23-32.
135. Yu FX, Luo J, Mo JS, Liu G, Kim YC, Meng Z, Zhao L, Peyman G, Ouyang H, and Jiang W et al. (2014) Mutant Gq/11 promote uveal melanoma tumorigenesis by activating YAP. Cancer Cell 25:822-830.
136. Yu FX, Zhao B, Panupinthu N, Jewell JL, Lian I, Wang LH, Zhao J, Yuan H, Tumaneng K, and Li H et al. (2012) Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell 150:780-791.
137. Yuan J, Bae D, Cantrell D, Nel AE, and Rozengurt E (2002) Protein kinase D is a downstream target of protein kinase Ctheta. Biochem Biophys Res Commun 291:444-452.
138. Yuan J, Slice LW, Gu J, and Rozengurt E (2003) Cooperation of Gq, Gi, and G12/13 in protein kinase D activation and phosphorylation induced by lysophosphatidic acid. J Biol Chem 278:4882-4891.
139. Yuan J, Slice LW, and Rozengurt E (2001) Activation of protein kinase D by signaling through Rho and the alpha subunit of the heterotrimeric G protein G13. J Biol Chem 276:38619-38627.
140. Zhang L, Malik S, Pang J, Wang H, Park KM, Yule DI, Blaxall BC, and Smrcka AV (2013) Phospholipase Cε hydrolyzes perinuclear phosphatidylinositol 4-phosphate to regulate cardiac hypertrophy. Cell 153:216-227.
141. Zhao B, Li L, Lu Q, Wang LH, Liu CY, Lei Q, and Guan KL (2011) Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Genes Dev 25:51-63.
142. Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim J, Xie J, Ikenoue T, Yu J, and Li L et al. (2007) Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev 21:2747-2761.
143. Zhao B, Ye X, Yu J, Li L, Li W, Li S, Yu J, Lin JD, Wang CY, and Chinnaiyan AM et al. (2008) TEAD mediates YAP-dependent gene induction and growth control. Genes Dev 22:1962-1971.
144. Zhao D, Kuhnt-Moore S, Zeng H, Wu JS, Moyer MP, and Pothoulakis C (2003) Neurotensin stimulates IL-8 expression in human colonic epithelial cells through Rho GTPase-mediated NF-kappa B pathways. Am J Physiol Cell Physiol 284:C1397-C1404.
145. Zhao X, Ding EY, Yu OM, Xiang SY, Tan-Sah VP, Yung BS, Hedgpeth J, Neubig RR, Lau LF, and Brown JH et al. (2014) Induction of the matricellular protein CCN1 through RhoA and MRTF-A contributes to ischemic cardioprotection. J Mol Cell Cardiol 75:152-161.